Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD
Public ClinicalTrials.gov record NCT03247530. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) 100 and 200 mg Efficacy and Safety in Children With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Study identification
- NCT ID
- NCT03247530
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Supernus Pharmaceuticals, Inc.
- Industry
- Enrollment
- 477 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- 100mg SPN-812 Drug
- 200mg SPN-812 Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 19, 2017
- Primary completion
- Sep 11, 2018
- Completion
- Sep 11, 2018
- Last update posted
- Jul 1, 2021
2017 – 2018
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Harmonex Neuroscience Research | Dothan | Alabama | 36303 | — |
| Indago Research & Health Center, Inc. | Hialeah | Florida | 33012 | — |
| Advanced Clinical Research | Meridian | Idaho | 83642 | — |
| Finger Lakes Clinical Research | Rochester | New York | 14618 | — |
| Houston Clinical Trials | Houston | Texas | 77098 | — |
| Family Psychiatry of the Woodlands | The Woodlands | Texas | 77381 | — |
| Aspen Clinical Research | Orem | Utah | 84058 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03247530, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2021 · Synced Jul 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03247530 live on ClinicalTrials.gov.